Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference
(WorldNews France)

PRESS RELEASE Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference Dr. André Choulika to Serve as Panelist for "Humankind vs. Cancer: The Scorecard" New York, N.Y. - April 27, 2017 - Cellectis (Alternext: ALCLS; Nasdaq: CLLS), a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced that the Company`s founder, Chairman and CEO, Dr. André Choulika, has been selected as a speaker for the 2017 Milken Institute Global Conference. Dr. Choulika will participate as a panelist for a session titled, "Humankind vs. Cancer: The Scorecard"...